Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Articles

Increased Rate of Cori Cycle in Obese Subjects With NIDDM and Effect of Weight Reduction

  1. Joanna K Zawadzki,
  2. Robert R Wolfe,
  3. David M Mott,
  4. Stephen Lillioja,
  5. Barbara V Howard and
  6. Clifton Bogardus
  1. Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Phoenix, Arizona Shriners' Hospital-Burns Institute Galveston, Texas
  1. Address correspondence and reprint requests to Joanna K. Zawadzki, MD, Division of Endocrinology, Room 2215, Georgetown University Medical Center, 3800 Reservoir Road, NW, Washington, DC 20007.
Diabetes 1988 Feb; 37(2): 154-159. https://doi.org/10.2337/diab.37.2.154
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

To determine the contribution of the rate of glucose recycling via the Cori cycle (glucose→3-carbon compounds→glucose) to the higher rate of endogenous glucose production (EGPR) in subjects with non-insulin-dependent diabetes mellitus (NIDDM), we studied eight obese, weight-stabilized diabetic Pima Indians before [93.1 ± 5.4 kg, 38 ± 2% body fat, fasting plasma glucose (FPG) 254 ± 11 mg/dl] and after (87.7 ± 4.7 kg, 36 ± 2% body fat, FPG 153 ± 17 mg/dl) a 5-wk weight-loss diet and eight obese Indians (95.0 ± 4.2 kg, 36 ± 2% body fat, FPG 97 ± 1 mg/dl) with normal glucose tolerance. EGPR and glucose recycling rate were measured during a 4-h primed continuous tracer infusion of [1-13C]glucose, and the rate of reincorporation of 1-13C of glucose into C2–6 positions in glucose was quantified by gas chromatography mass spectrometry. Substrate utilization rates were measured by simultaneous indirect calorimetry. EGPR (corrected for measured rate of recycling) decreased in the diabetic subjects from 3.80 to 2.74 mg·min−1·kg−1 fat-free mass (FFM) (P < .01) after weight loss, approaching the rate observed in nondiabetic subjects (2.09 mg·min−1·kg−1 FFM). The decrease in EGPR was associated with a decrease in nonoxidative carbohydrate disposal. Before weight loss, the measured rate of [1-13C]glucose recycling was higher in diabetic (0.23 ± 0.02 mg · min−1 · kg−1 FFM) than in nondiabetic (0.14 ± 0.01 mg min−1 · kg−1 FFM, P < .005) subjects. The glucose recycling rate did not change in diabetic subjects after weight loss (0.20 mg · min−1 · kg−1 FFM). We conclude that the rates of endogenous glucose production and the Cori cycle are increased in subjects with NIDDM compared with the rates observed in obese subjects with normal glucose tolerance. After a modest weight loss, the endogenous glucose production rate, but not the glucose recycling rate, in diabetic subjects approaches the rate observed in obese nondiabetic subjects.

  • Received November 6, 1986.
  • Revision received July 30, 1987.
  • Accepted July 30, 1987.
  • Copyright © 1988 by the American Diabetes Association
PreviousNext
Back to top

In this Issue

February 1988, 37(2)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Increased Rate of Cori Cycle in Obese Subjects With NIDDM and Effect of Weight Reduction
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Increased Rate of Cori Cycle in Obese Subjects With NIDDM and Effect of Weight Reduction
Joanna K Zawadzki, Robert R Wolfe, David M Mott, Stephen Lillioja, Barbara V Howard, Clifton Bogardus
Diabetes Feb 1988, 37 (2) 154-159; DOI: 10.2337/diab.37.2.154

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Increased Rate of Cori Cycle in Obese Subjects With NIDDM and Effect of Weight Reduction
Joanna K Zawadzki, Robert R Wolfe, David M Mott, Stephen Lillioja, Barbara V Howard, Clifton Bogardus
Diabetes Feb 1988, 37 (2) 154-159; DOI: 10.2337/diab.37.2.154
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas
  • Enhanced Responsiveness of Blood Pressure to Sodium Intake and to Angiotensin II Is Associated With Insulin Resistance in IDDM Patients With Mcroalbuminuria
  • Prolonged Survival of Rat Islet and Skin Xenografts in Mice Treated with Donor Splenocytes and Anti-CD154 Monoclonal Antibody
Show more Original Articles

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.